These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 15979294)

  • 21. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer.
    Janakiram NB; Mohammed A; Rao CV
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):507-23. PubMed ID: 22015691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity.
    Brady HR; Serhan CN
    Curr Opin Nephrol Hypertens; 1996 Jan; 5(1):20-7. PubMed ID: 8834158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoxin signaling in neutrophils and their role in periodontal disease.
    Kantarci A; Van Dyke TE
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):289-99. PubMed ID: 15979867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators.
    Serhan CN; Takano T; Gronert K; Chiang N; Clish CB
    Clin Chem Lab Med; 1999 Mar; 37(3):299-309. PubMed ID: 10353476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
    O'Meara YM; Brady HR
    Kidney Int Suppl; 1997 Mar; 58():S56-61. PubMed ID: 9067945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock.
    Lefer AM; Lefer DJ
    Annu Rev Pharmacol Toxicol; 1993; 33():71-90. PubMed ID: 8494355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of atherosclerotic plaque inflammation.
    Bäck M; Weber C; Lutgens E
    J Intern Med; 2015 Nov; 278(5):462-82. PubMed ID: 25823439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specialised lipid mediators and their targets.
    Crean D; Godson C
    Semin Immunol; 2015 May; 27(3):169-76. PubMed ID: 26048571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The resolution of inflammation: Principles and challenges.
    Headland SE; Norling LV
    Semin Immunol; 2015 May; 27(3):149-60. PubMed ID: 25911383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of leukocyte recruitment in the inflammatory process.
    Ley K
    Cardiovasc Res; 1996 Oct; 32(4):733-42. PubMed ID: 8915191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
    Yacoubian S; Serhan CN
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG; Khreiss T; József L
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid mediator networks in cell signaling: update and impact of cytokines.
    Serhan CN; Haeggström JZ; Leslie CC
    FASEB J; 1996 Aug; 10(10):1147-58. PubMed ID: 8751717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid mediators in epithelial cell-cell interactions.
    Colgan SP
    Cell Mol Life Sci; 2002 May; 59(5):754-60. PubMed ID: 12088276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A twist in anti-inflammation: annexin 1 acts via the lipoxin A4 receptor.
    Gavins FN; Sawmynaden P; Chatterjee BE; Perretti M
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):211-9. PubMed ID: 15982865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis.
    Kantarci A; Oyaizu K; Van Dyke TE
    J Periodontol; 2003 Jan; 74(1):66-75. PubMed ID: 12593599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.